Emobot Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$189K
- Investors
-
6
Emobot General Information
Description
Developer of an artificial intelligence-based behavioral and emotional monitoring platform designed for diagnosing and treating mood disorders. The company's platform uses emotion-analysis technology to support continuous monitoring of depressive symptoms, assist clinicians in diagnostic evaluation, and deliver digital therapeutic interventions, enabling clinicians to improve diagnostic accuracy, supporting patients with accessible therapeutic tools, and permitting pharmaceutical companies to enhance clinical-trial evaluation and reduce development risks.
Contact Information
Website
www.emobot.frCorporate Office
- 15 rue des Halles
- 75001 Paris
- France
Corporate Office
- 15 rue des Halles
- 75001 Paris
- France
Emobot Timeline
Emobot Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Seed Round | 10-Apr-2025 | $189K | Completed | Generating Revenue | ||
| 5. Accelerator/Incubator | 11-Oct-2022 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Apr-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 01-Jan-2022 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | $200K | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | $200K | $200K | Completed | Generating Revenue |
Emobot Patents
Emobot Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4831996-A1 | Device for automatic adaptation over time of an adaptative therapy for a user affected by a mental disorder | Pending | 23-Apr-2025 | ||
| WO-2026224226-A1 | Device for automatic adaptation over time of an adaptative therapy for a user affected by a mental disorder | Pending | 23-Apr-2025 | ||
| WO-2026057891-A1 | Device and computer program product for assisting a diagnosis of a patient affected by a psychiatric disorder | Pending | 16-Sep-2024 | ||
| EP-4687152-A1 | Device for collecting a data from a person at risk of a psychiatric disorder | Pending | 01-Aug-2024 | ||
| WO-2026027738-A1 | Device for collecting a data from a person at risk of a psychiatric disorder | Pending | 01-Aug-2024 | G16H50/20 |
Emobot Signals
Emobot Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Berkeley SkyDeck Fund | Venture Capital | Minority | ||
| iPEPS-ICM | Accelerator/Incubator | |||
| Station F | Accelerator/Incubator | |||
| 21st by CentraleSupélec | Accelerator/Incubator | |||
| Berkeley SkyDeck | Accelerator/Incubator | Minority |
Emobot FAQs
-
When was Emobot founded?
Emobot was founded in 2022.
-
Where is Emobot headquartered?
Emobot is headquartered in Paris, France.
-
What is the size of Emobot?
Emobot has 14 total employees.
-
What industry is Emobot in?
Emobot’s primary industry is Therapeutic Devices.
-
Is Emobot a private or public company?
Emobot is a Private company.
-
What is the current valuation of Emobot?
The current valuation of Emobot is .
-
What is Emobot’s current revenue?
The current revenue for Emobot is .
-
How much funding has Emobot raised over time?
Emobot has raised $389K.
-
Who are Emobot’s investors?
Berkeley SkyDeck Fund, iPEPS-ICM, Station F, 21st by CentraleSupélec, and Berkeley SkyDeck are 5 of 6 investors who have invested in Emobot.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process